Guardant Non Current Assets Total from 2010 to 2024

GH Stock  USD 30.98  0.30  0.98%   
Guardant Health's Non Current Assets Total are increasing with slightly volatile movements from year to year. Non Current Assets Total are predicted to flatten to about 402.7 M. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2017-12-31
Previous Quarter
319.4 M
Current Value
312 M
Quarterly Volatility
257.7 M
 
Covid
Check Guardant Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardant Health's main balance sheet or income statement drivers, such as Tax Provision of 719.2 K, Net Interest Income of 34.4 M or Interest Income of 37.1 M, as well as many indicators such as Price To Sales Ratio of 5.1, Dividend Yield of 0.0022 or PTB Ratio of 13.78. Guardant financial statements analysis is a perfect complement when working with Guardant Health Valuation or Volatility modules.
  
Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Latest Guardant Health's Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Guardant Health over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Guardant Health's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Guardant Health's overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

Guardant Non Current Assets Total Regression Statistics

Arithmetic Mean227,472,446
Geometric Mean73,937,299
Coefficient Of Variation131.29
Mean Deviation231,269,202
Median100,003,000
Standard Deviation298,641,397
Sample Variance89186.7T
Range1.1B
R-Value0.72
Mean Square Error45757T
R-Squared0.52
Significance0
Slope48,320,839
Total Sum of Squares1248613.6T

Guardant Non Current Assets Total History

2024402.7 M
2023439.3 M
2022418.4 M
20211.1 B
2020383.4 M
2019365.2 M
2018118.4 M

About Guardant Health Financial Statements

Investors use fundamental indicators, such as Guardant Health's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Guardant Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Non Current Assets Total439.3 M402.7 M

Currently Active Assets on Macroaxis

Check out the analysis of Guardant Health Correlation against competitors.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.28)
Revenue Per Share
5.7
Quarterly Revenue Growth
0.339
Return On Assets
(0.16)
Return On Equity
(6.09)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.